Phase I study of selinexor, ixazomib and low-dose dexamethasone in patients with relapsed or refractory multiple myeloma

Shranjeno v:
Bibliografske podrobnosti
izdano v:Clin Lymphoma Myeloma Leuk
Main Authors: Salcedo, Meghan, Lendvai, Nikoletta, Mastey, Donna, Schlossman, Julia, Hultcrantz, Malin, Korde, Neha, Mailankody, Sham, Lesokhin, Alexander, Hassoun, Hani, Smith, Eric, Shah, Urvi, Diab, Victoria, Werner, Kelly, Landau, Heather, Lahoud, Oscar, Drullinsky, Pamela, Shah, Gunjan, Chung, David, Scordo, Michael, Giralt, Sergio, Landgren, Ola
Format: Artigo
Jezik:Inglês
Izdano: 2019
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7405911/
https://ncbi.nlm.nih.gov/pubmed/32001193
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.clml.2019.12.013
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki